Patients with thrombocytopenia, microangiopathic hemolysis, neurological symptoms, fever, and renal impairment may be tested for von Willebr and factor (vWF)- cleaving protease(ADAMTS13) activity and ADAMTS13 inhibitors [29]. Here, ADAMTS13 is linked to Thrombocytopenia.